Three organisations from across the Highlands and Islands have teamed up in a new collaboration to boost life sciences in the region. Highlands and Islands Enterprise (HIE), the University of the Highlands and Islands, and NHS Highland have signed a memorandum of understanding (MoU) as they progress joint initiatives on Inverness Campus. These teams will focus on key regional themes such as remote and rural...
By Dave Tudor, Chair of Life Sciences Scotland Industry Leadership Group Over the centuries Scotland has played a significant role in medical advancements and scientific innovations. But these aren’t confined to the past; this is Scotland’s future through the work and growth of Scotland’s life sciences sector. Scotland is a centre of life sciences excellence from the cloning of Dolly the sheep to advancements in...
Synpromics Ltd have announced a new collaboration with UCL to generate a range of synthetic gene promoters for the central nervous system (CNS), to develop a gene therapy for Parkinson’s disease. The collaborative project will see the company develop novel gene promoters to specifically control the expression of therapeutic genes in different sub-populations of neurones. The partnership is expected to last 24 months with the...
Concept Life Sciences’ recent acquisition of Aquila BioMedical has quickly produced a return—an extended contract with Macrophage Pharma to support its preclinical immuno-oncology programs. Aquila will run a few in vitro, in vivo and ex vivo analyses to help Macrophage decide on the best candidate to enter the clinic. U.K.-based Macrophage targets cancer with its proprietary Esterase Sensitive Motif (ESM) technology, which delivers small-molecule drugs...
Former chief executive of GlaxoSmithKline (GSK), Sir Andrew Witty has been chosen to chair the Accelerate Access Collaborative (AAC) in efforts from the UK Government to accelerate the approval of important new medical therapies. The organisation will be responsible for coordinating the various government bodies that will decide which new treatments should be selected for the Government’s new Accelerated Access Pathway (AAP) which will come...
Life sciences incubation business, BioCity, are set to further expand in Aberdeen’s world-class life sciences cluster following success at the headquarters in Nottingham. Delivered by BioCity Group in partnership with private sector economic development body Opportunity North East (ONE), the ONE Life Sciences Accelerator Programme will launch with a boot camp in early December, followed by a 12-week DEVELOP programme starting in January 2018. Toby...